Saturday, September 6, 2008 - 8:36PM EST

Clinical Trials

1. Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study.

Author
Wang XH; Liu X; Sun YM; Shi HF; Zhou L; Gu JN;
Institution
Department of Cardiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200030, People's Republic of China.
Journal
Europace. 2008 May;10(5):600-5.
Abstract URL
Click here to view abstract

2. Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation.

Author
Boldt LH; Rolf S; Huemer M; Parwani AS; Luft FC; Dietz R; Haverkamp W; Boldt LH; Rolf S; Huemer M; Parwani AS; Luft FC; Dietz R; Haverkamp W;
Institution
Department of Cardiology, Charite-Campus Virchow Clinic, Berlin, Germany. leif-hendrik.boldt@charite.de
Journal
Am Heart J. 2008 May;155(5):890-5. Epub 2008 Feb 15.
Abstract URL
Click here to view abstract

3. Efficacy and safety of the additional bepridil treatment in patients with atrial fibrillation refractory to class I antiarrhythmic drugs.

Author
Miyaji K; Tada H; Fukushima Kusano K; Hashimoto T; Kaseno K; Hiramatsu S; Tadokoro K; Naito S; Nakamura K; Oshima S; Taniguchi K; Ohe T;
Institution
Division of Cardiology, Gunma Prefectural Cardiovascular Center, Maebashi, and Department of Cardiovascular Medicine, Okayama University Graduated School of Medicine, Density and Pharmaceutical Science, Japan.
Journal
Circ J. 2007 Aug;71(8):1250-7.
Abstract URL
Click here to view abstract

4. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Author
Mant J; Hobbs FD; Fletcher K; Roalfe A; Fitzmaurice D; Lip GY; Murray E;
Institution
Primary Care Clinical Sciences, University of Birmingham, Birmingham, UK. j.w.mant@bham.ac.uk
Journal
Lancet. 2007 Aug 11;370(9586):493-503.
Abstract URL
Click here to view abstract

5. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.

Author
Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
Institution
Cardiology Division, Veterans Affairs Greater Los Angeles Healthcare System and the David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA. bsingh@ucla.edu
Journal
N Engl J Med. 2007 Sep 6;357(10):987-99.
Abstract URL
Click here to view abstract

6. Rhythm control versus rate control for atrial fibrillation and heart failure.

Author
Roy D; Talajic M; Nattel S; Wyse DG; Dorian P; Lee KL; Bourassa MG; Arnold JM; Buxton AE; Camm AJ; Connolly SJ; Dubuc M; Ducharme A; Guerra PG; Hohnloser SH; Lambert J; Le Heuzey JY; O'Hara G; Pedersen OD; Rouleau JL; Singh BN; Stevenson LW; Stevenson WG; Thibault B; Waldo AL;
Institution
Montreal Heart Institute and the Universite de Montreal, Montreal, QC H1T 1C8, Canada. d_roy@icm-mhi.com
Journal
N Engl J Med. 2008 Jun 19;358(25):2667-77.
Abstract URL
Click here to view abstract

7. Dose-response effect of flecainide in patients with symptomatic paroxysmal atrial fibrillation and/or flutter monitored with trans-telephonic electrocardiography: a multicenter, placebo-controlled, double-blind trial.

Author
Atarashi H; Ogawa S; Inoue H; Hamada C;
Institution
Department of Internal Medicine, Nippon Medical School, Tama-Nagayama Hospital, Japan. atarashi@nms.ac.jp
Journal
Circ J. 2007 Mar;71(3):294-300.
Abstract URL
Click here to view abstract

8. Stepwise linear approach to catheter ablation of atrial fibrillation.

Author
Yao Y; Zheng L; Zhang S; He DS; Zhang K; Tang M; Chen K; Pu J; Wang F; Chen X;
Institution
Clinical EP Laboratory and Arrhythmia Service Center of Fuwai Heart Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China. ianyao@263.net.cn
Journal
Heart Rhythm. 2007 Dec;4(12):1497-504. Epub 2007 Aug 11.
Abstract URL
Click here to view abstract

9. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.

Author
Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J;
Institution
AstraZeneca R&D, Medical Science, Molndal, Sweden. marco.tangelder@astrazeneca.com
Journal
Am Heart J. 2008 Feb;155(2):382-7.
Abstract URL
Click here to view abstract

10. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial.

Author
Yared JP; Bakri MH; Erzurum SC; Moravec CS; Laskowski DM; Van Wagoner DR; Mascha E; Thornton J;
Institution
Department of Cardiothoracic Anesthesiology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. yaredj@ccf.org
Journal
J Cardiothorac Vasc Anesth. 2007 Feb;21(1):68-75. Epub 2006 Feb 14.
Abstract URL
Click here to view abstract
Pages: 1 2 3